Biotechnology · Healthcare
Chief Accounting Officer
2020-11-11–present
Chief Accounting Officer
Opus Genetics, Inc. (IRD)Equibles does not estimate personal net worth.
Get an email with a short summary when Opus Genetics, Inc. publishes a filing, an earnings call transcript or a press release.
Get IRD alertsAmy Rabourn is recorded as Chief Accounting Officer at Opus Genetics, Inc. (IRD) since November 11, 2020. The proxy statement of Opus Genetics, Inc. reports total compensation of $789,918 for Amy Rabourn in fiscal 2023, including a base salary of $305,000. Disclosed compensation is on record for 5 fiscal years. Opus Genetics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Opus Genetics, Inc. includes Dr. George Magrath (CEO and Board Member), George Magrath (CEO and Board Member), George Magrath, M.D., M.B.A., M.S. (CEO and Board Member) and 7 others.
2020-11-11–present
Proxy statement
Start not stated–present
Last confirmed March 23, 2026
Biotechnology · Healthcare
Chief Accounting Officer
2020-11-11–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Opus Genetics, Inc. (IRD) | Senior Vice President of Finance | $305,000 | $789,918 |
| 2022 | Opus Genetics, Inc. (IRD) | Senior Vice President of Finance | $260,000 | $499,267 |
| 2021 | Opus Genetics, Inc. (IRD) | Vice President of Finance | $240,000 | $332,093 |
| 2020 | Opus Genetics, Inc. (IRD) | Vice President of Finance | $33,333 | $266,656 |
| 2019 | Opus Genetics, Inc. (IRD) | Vice President of Finance | — | — |
No call appearances or filed executive changes recorded yet.